Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
MARIA: Melatonin in Acute Myocardial Infarction
NCT00640094Phase 2Terminated
- Start
- May 2013
- Primary completion
- Mar 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in acute myocardial infarction (AMI) comparing Melatonin with Placebo (2 arms). Primary endpoint: Infarct Size. Started May 2013; status: terminated.
02
Drugs
melatonin
03
Conditions
acute myocardial infarction (AMI)
Beyond the preview
Go deeper on NCT00640094.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00640094.